Between Jan 11 and 17, Accrelist : QZG -2.22% executive chairman and managing director Terence Tea Yeok Kian acquired 800,100 shares at S$0.041 per share.

 

With a consideration of S$33,105 this increased his direct interest in the Catalist-listed company from 23.19 per cent to 23.44 per cent.

 

Dr Tea is also deemed interested in the 4,359,100 issued shares held by his wife Aileen Sim. This brings his total interest to 24.84 per cent and followed his acquisition of 2,365,900 shares at S$0.039 per share between Jan 4 and 9.

Between Jan 4 and 9, Accrelist : QZG +2.38% executive chairman and managing director Terence Tea acquired 2,365,900 shares at S$0.039 per share. With a consideration of S$92,816, this increased his direct interest in the Catalist-listed company from 22.43 per cent to 23.19 per cent. He is also deemed interested in the 4,359,100 issued shares held by his wife, Aileen Sim. This brings his total interest to 24.59 per cent.

 

Tea is responsible for the overall growth of the group, and his main role is to determine its strategic direction and acquire and nurture new businesses, while driving the formulation and implementation of business plans and strategies. Tea&rsquo s comprehensive knowledge and experience of the industry has aided the group to spot growth opportunities, especially during its restructuring period from 2013 to 2017.

 

Accrelist continues to actively pursue new opportunities, with a growing focus on medical aesthetics.

 

In addition, as a majority shareholder, Accrelist currently holds a controlling stake in Jubilee Industries Holdings : NHD 0%, a one-stop solutions provider within the electronic manufacturing services space. Through its mechanical business unit (MBU), Jubilee engages primarily in precision plastic injection moulding and mould design and fabrication services.

 

Tea also serves as the executive chairman and CEO of Jubilee. Accrelist has also provided support to Jubilee in terms of market expansion, cost-review exercises and capital control improvements.

 

Accrelist is organised into four major operating segments: financial technology the electronic components distribution business unit MBU and aesthetic medical services (AMS). For its H1 FY2024 (ended Sep 30), Accrelist reported revenue of S$8.3 million, S$1.6 million less than the S$9.9 million in H1 FY2023.

 

The group&rsquo s AMS segment contributed S$6.2 million of the S$8.3 million revenue reported for H1 FY2024. Accrelist noted its AMS segment is supported by resilient demand in an expanding market, with favourable long-term prospects.

 

The company added that amid an ageing population with rising affluence, the growing acceptance and accessibility of minimally invasive procedures has opened up new opportunities, as younger customers and men begin to seek aesthetic treatments.

 

The MBU segment in turn contributed S$1.7 million of the S$8.3 million revenue reported for H1 FY2024. This segment provides mould design and fabrication services for consumer electronics, household appliances, automotive and computer peripherals, as well as precision plastic injection moulding services for their customers&rsquo finished products.

 

The company noted in November that the MBU segment would continue to focus on its strategy of diversifying its customer base and expanding its product offering with higher margins, such as the development of submodule assemblies for automotives, to increase revenue amid the general automotive industry slowdown.

On Apr 19, Accrelist : QZG +3.28% executive chairman and managing director Terence Tea Yeok Kian acquired 170,000 shares at S$0.06 per share. With a consideration of S$10,258, this increased his total interest in the Catalist-listed investment holding company from 23.10 per cent to 23.16 per cent.

 

Tea is responsible for the overall growth of the group, leading its strategic direction, including acquiring and nurturing new businesses.

 

AddValue Technologies

On April 20, AddValue Technologies : A31 0% independent and non-executive chairman Richard Denny acquired one million shares at an average price of S$0.01 per share. This increased his direct interest in the satellite communications company from 0.14 per cent to 0.17 per cent.

 

Denny, an Australian national, has had over 40 years of experience in the space and satellite sector.

 

CATALIST-LISTED Accrelist : QZG +5.17% will acquire a 51 per cent stake in four medical aesthetic clinics for S$550,000, the group said late on Tuesday (Apr 18).

 

Accrelist, which has businesses in skincare products, medical aesthetics and electronics solutions, will acquire 102,000 shares in SJY Medical, which operates the four clinics at Novena Medical Centre, NEX Serangoon, Jurong Point, and SingPost Centre.

 

The book value of the sale shares is valued at S$358,507 for the Aug 1, 2022, to Mar 31, 2023, period.

 

Assuming the deal was completed on Mar 31, 2023, Accrelist estimates its loss per share to narrow to S$0.413 from S$0.0419, based on pro forma estimates. Meanwhile, its net tangible assets per share will rise to S$0.1013 from S$0.0984.

 

When the deal is completed, SJY Medical will become an Accrelist subsidiary. Its four clinics will also be rebranded under Accrelist Medical Aesthetics (AM Aesthetics) while retaining existing doctors.

 

Accrelist executive chairman and managing director Terence Tea said: &ldquo We remain confident in AM Aesthetics&rsquo long-term prospects amidst an ageing population with rising affluence and growing acceptance of minimally invasive procedures.&rdquo

 

He also said that AM Aesthetics will continue to seek growth opportunities across the region.

 

AM Aesthetics operates a chain of medical aesthetics clinics &ndash nine in Singapore and one in Malaysia. It will open two more aesthetics clinics in Northpoint City and VivoCity later in the year, Accrelist said.

 

It also noted plans to open AM Aesthetics clinics in Bangkok, Thailand and Kuala Lumpur, Malaysia.

 

Accrelist also holds a 53.31 per cent controlling stake in Catalist-listed Jubilee Industries : NHD 0%. Jubilee said on Mar 23 that it would sell its remaining 86 per cent stake in its electronics business unit for US$15.9 million in cash.